The FDA approved GSK’s respiratory syncytial virus vaccine intended for adults 60 and older on May 3. It’s the first RSV vaccine cleared in the world, the drugmaker said.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st RSV vaccine
